Wirsching H-G, Weller M. Glioblastoma. In: Moliterno Gunel J, Piepmeier JM, Baehring JM, editors. Malignant Brain Tumors : State-of-the-Art Treatment. Cham: Springer International Publishing; 2017. p. 265–88.

Google Scholar 

Zong H, Parada LF, Baker SJ. Cell of origin for malignant gliomas and its implication in therapeutic development. Cold Spring Harb Perspect Biol. 2015;7:a020610.

Google Scholar 

Zeng A, Wei Z, Rabinovsky R, Jun HJ, El Fatimy R, Deforzh E, et al. Glioblastoma-derived extracellular vesicles facilitate transformation of astrocytes via reprogramming oncogenic metabolism. iScience. 2020;23(8):101420.

CAS  Google Scholar 

Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA: Cancer J for Clin. 2020;70(4):299–312.

Google Scholar 

Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee ShU. Glioblastoma Multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev. 2017;18(1):3–9.

Google Scholar 

Touat M, Idbaih A, Sanson M, Ligon KL. Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol. 2017;28(7):1457–72.

CAS  Google Scholar 

Davis ME. Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs. 2016;20(5 Suppl):S2-8.

Google Scholar 

Gilard V, Tebani A, Dabaj I, Laquerrière A, Fontanilles M, Derrey S, et al. Diagnosis and management of glioblastoma: a comprehensive perspective. J Pers Med. 2021;11(4):258.

Google Scholar 

Bai R, Zhu J, Bai Z, Mao Q, Zhang Y, Hui Z, et al. Second generation β-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma. J Enzyme Inhib Med Chem. 2022;37(1):379–85.

CAS  Google Scholar 

Lan J, Chen L, Li Z, Liu L, Zeng R, He Y, et al. Multifunctional biomimetic liposomes with improved tumor-targeting for TNBC treatment by combination of chemotherapy antiangiogenesis and immunotherapy. Adv Healthc Mater. 2024. https://doi.org/10.1002/adhm.202400046.

Article  Google Scholar 

Adams BD, Parsons C, Walker L, Zhang WC, Slack FJ. Targeting noncoding RNAs in disease. J Clin Investig. 2017;127(3):761–71.

Google Scholar 

Zhou Y, Li Q, Pan R, Wang Q, Zhu X, Yuan C, et al. Regulatory roles of three miRNAs on allergen mRNA expression in Tyrophagus putrescentiae. Allergy. 2022;77(2):469–82.

CAS  Google Scholar 

Hombach S, Kretz M. Non-coding RNAs: Classification, Biology and Functioning. In: Slaby O, Calin GA, editors. Non-coding RNAs in Colorectal Cancer. Cham: Springer International Publishing; 2016. p. 3–17.

Google Scholar 

Sun W, Shi Y, Wang Z, Zhang J, Cai H, Zhang J, Huang D. Interaction of long-chain non-coding RNAs and important signaling pathways on human cancers. Int J Oncol. 2018;53(6):2343–55.

CAS  Google Scholar 

Laurent GS, Wahlestedt C, Kapranov P. The Landscape of long noncoding RNA classification. Trends Genet. 2015;31(5):239–51.

Google Scholar 

Wang D, Farhana A. Biochemistry, RNA Structure. 2020.

Brosnan CA, Voinnet O. The long and the short of noncoding RNAs. Curr Opin Cell Biol. 2009;21(3):416–25.

CAS  Google Scholar 

Chen Y, Tan S, Liu M, Li J. LncRNA TINCR is downregulated in diabetic cardiomyopathy and relates to cardiomyocyte apoptosis. Scand Cardiovasc J. 2018;52(6):335–9.

CAS  Google Scholar 

Ebrahimnezhad M, Asl SH, Rezaie M, Molavand M, Yousefi B, Majidinia M. lncRNAs: New players of cancer drug resistance via targeting ABC transporters. IUBMB Life. 2024. https://doi.org/10.1002/iub.2888.

Article  Google Scholar 

Mizushima N. Autophagy: process and function. Genes Dev. 2007;21(22):2861–73.

CAS  Google Scholar 

Yan X, Zhou R, Ma Z. Autophagy—cell survival and death. In: Qin Z-H, editor. Autophagy: Biology and Diseases: Basic Science. Singapore: Springer Singapore; 2019. p. 667–96.

Google Scholar 

Das G, Shravage BV, Baehrecke EH. Regulation and function of autophagy during cell survival and cell death. Cold Spring Harb Perspect Biol. 2012;4(6):a008813.

Google Scholar 

Thorburn A. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis. 2008;13(1):1–9.

CAS  Google Scholar 

Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014;20(3):460–73.

CAS  Google Scholar 

Gousias K, Theocharous T, Simon M. Mechanisms of cell cycle arrest and apoptosis in glioblastoma. Biomedicines. 2022;10(3):564.

CAS  Google Scholar 

Torrisi F, Alberghina C, D’Aprile S, Pavone AM, Longhitano L, Giallongo S, et al. The hallmarks of glioblastoma: heterogeneity, intercellular crosstalk and molecular signature of invasiveness and progression. Biomedicines. 2022;10(4):806.

CAS  Google Scholar 

Li X, Wu C, Chen N, Gu H, Yen A, Cao L, et al. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016;7(22):33440–50.

Google Scholar 

Khabibov M, Garifullin A, Boumber Y, Khaddour K, Fernandez M, Khamitov F, et al. Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review). Int J Oncol. 2022;60(6):1.

Google Scholar 

Esemen Y, Awan M, Parwez R, Baig A, Rahman S, Masala I, et al. Molecular pathogenesis of glioblastoma in adults and future perspectives: a systematic review. Int J Mol Sci. 2022;23(5):2607.

CAS  Google Scholar 

Barzegar Behrooz A, Talaie Z, Jusheghani F, Łos MJ, Klonisch T, Ghavami S. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. Int J Mol Sci. 2022;23(3):1353.

CAS  Google Scholar 

Hashemi M, Etemad S, Rezaei S, Ziaolhagh S, Rajabi R, Rahmanian P, et al. Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions. Biomed Pharmacother. 2023;158:114204.

CAS  Google Scholar 

Bahar ME, Kim HJ, Kim DR. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8(1):455.

CAS  Google Scholar 

Wu W, Li H, Wang Z, Dai Z, Liang X, Luo P, et al. The tertiary lymphoid structure-related signature identified PTGDS in regulating PD-L1 and promoting the proliferation and migration of glioblastoma. Heliyon. 2024;10(1):e23915.

CAS  Google Scholar 

Mao H, Lebrun DG, Yang J, Zhu VF, Li M. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest. 2012;30(1):48–56.

Google Scholar 

Xu C, Wu X, Zhu J. VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2. Sci World J. 2013;2013:417413.

Google Scholar 

Rajaratnam V, Islam MM, Yang M, Slaby R, Ramirez HM, Mirza SP. Glioblastoma: pathogenesis and current status of chemotherapy and other novel treatments. Cancers (Basel). 2020;12(4):937.

CAS  Google Scholar 

Liu Y, Lang F, Chou FJ, Zaghloul KA, Yang C. Isocitrate Dehydrogenase mutations in glioma: genetics, biochemistry, and clinical indications. Biomedicines. 2020;8(9):294.

CAS  Google Scholar 

Hawkins CC, Jones AB, Gordon ER, Williford SE, Harsh Y, Ziebro JK, et al. Targeting acid ceramidase inhibits glioblastoma cell migration through decreased AKT signaling. Cells. 2022;11(12):1873.

CAS  Google Scholar 

Lai M, Realini N, La Ferla M, Passalacqua I, Matteoli G, Ganesan A, et al. Complete acid ceramidase ablation prevents cancer-initiating cell formation in melanoma cells. Sci Rep. 2017;7(1):7411.

Google Scholar 

Chantsalnyam T, Lim DY, Tayara H, Chong KT. ncRDeep: non-coding RNA classification with convolutional neural network. Comput Biol Chem. 2020;88:107364.

CAS  Google Scholar 

Hombach S, Kretz M. Non-coding RNAs: classification, biology and functioning. Adv Exp Med Biol. 2016;937:3–17.

CAS  Google Scholar 

Ahmadi D, Zarei M, Rahimi M, Khazaie M, Asemi Z, Mir SM, et al. Preparation and in-vitro evaluation of pH-responsive cationic cyclodextrin coated magnetic nanoparticles for delivery of methotrexate to the Saos-2 bone cancer cells. J Drug Deliv Sci Technol. 2020;57:101584.

CAS  Google Scholar 

Shi X, Valizadeh A, Mir SM, Asemi Z, Karimian A, Majidina M, et al. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells. Eur J Pharmacol. 2020;880:173138.

CAS  Google Scholar 

Park YB, Kim JM. Identification of long non-coding RNA-mRNA interactions and genome-wide lncRNA annotation in animal transcriptome profiling. J Anim Sci Technol. 2023;65(2):293–310.

CAS  Google Scholar 

Losko M, Kotlinowski J, Jura J. Long noncoding RNAs in metabolic syndrome related disorders. Mediators Inflamm. 2016;2016:5365209.

Google Scholar 

Szymański M, Erdmann VA, Barciszewski J. Noncoding regulatory RNAs database. Nucl Acids Res. 2003;31(1):429–31.

Google Scholar 

Gou L-T, Zhu Q, Liu M-F. Small RNAs: an expanding world with therapeutic promises. Fundam Res. 2023;3(5):676–82.

CAS  Google Scholar 

Qin T, Li J, Zhang KQ. Structure, regulation, and function of linear and circular long non-coding RNAs. Front Genet. 2020;11:150.

CAS  Google Scholar 

Deniz E, Erman B. Long noncoding RNA (lincRNA), a new paradigm in gene expression control. Funct Integr Genomics. 2017;17(2–3):135–43.

CAS  Google Scholar 

Zhang P, Wu W, Chen Q, Chen M. Non-Coding RNAs and their Integrated Networks. J Integr Bioinform. 2019;16(3):20190027.

Google Scholar 

Chang QQ, Chen CY, Chen Z, Chang S. LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer. Radiol Oncol. 2019;53(4):443–52.

Google Scholar 

Hingorani MM. Polymerase. In: Maloy S, Hughes K, editors. Brenner’s Encyclopedia of Genetics. 2nd ed. San Diego: Academic Press; 2013. p. 389–91.

Google Scholar 

Carter R, Drouin G. Structural differentiation of the three eukaryotic RNA polymerases. Genomics. 2009;94(6):388–96.

CAS  Google Scholar 

Bhat SA, Ahmad SM, Mumtaz PT, Malik AA, Dar MA, Urwat U, et al. Long non-coding RNAs: Mechanism of action and functional utility. Noncoding RNA Res. 2016;1(1):43–50.

Google Scholar